Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent

Biology of Sex Differences

Volumn 1, Issue 1, 2010, Pages

  Liu, Jun ^a,b   Ji, Hong ^a,b   Zheng, Wei ^a,b   Wu, Xie ^a   Zhu, Janet J ^b   Arnold, Arthur P ^c   Sandberg, Kathryn ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880110094     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-1-6     Document Type: Article

References (42)

1. Ingelfinger JR: Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens 2009, 18:79-84.
2. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000, 87:E1-9.
3. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 275:33238-33243.
4. Bindom SM, Lazartigues E: The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 2009, 302:193-202.
5. Imai Y, Kuba K, Ohto-Nakanishi T, Penninger JM: Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J 2010, 74:405-410.
6. Sandberg K, Ji H: Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease. Adv Ren Replace Ther 2003, 10:15-23. (Pubitemid 36278326)
7. Sullivan JC: Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1220-1226. (Pubitemid 351490641)
8. James GD, Sealey JE, Muller F, Alderman M, Madhavan S, Laragh JH: Renin relationship to sex, race and age in a normotensive population. J Hypertens Suppl 1986, 4:S387-389. (Pubitemid 17054558)
9. Pendergrass KD, Pirro NT, Westwood BM, Ferrario CM, Brosnihan KB, Chappell MC: Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol 2008, 295:H10-20.
10. Carrel L, Willard HF: X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404. (Pubitemid 40469185)
11. Itoh Y, Melamed E, Yang X, Kampf K, Wang S, Yehya N, Van Nas A, Replogle K, Band MR, Clayton DF, Schadt EE, Lusis AJ, Arnold AP: Dosage compensation is less effective in birds than in mammals. J Biol 2007, 6:2.
12. Johnston CM, Lovell FL, Leongamornlert DA, Stranger BE, Dermitzakis ET, Ross MT: Large-scale population study of human cell lines indicates that dosage compensation is virtually complete. PLoS Genet 2008, 4:e9.
13. Yang F, Babak T, Shendure J, Disteche CM: Global survey of escape from × inactivation by RNA-sequencing in mouse. Genome Res 2010, 20:614-622.
14. Davies W, Isles AR, Burgoyne PS, Wilkinson LS: X-linked imprinting: effects on brain and behaviour. Bioessays 2006, 28:35-44.
15. Cooley M, Bakalov V, Bondy CA: Lipid profiles in women with 45, X vs 46, XX primary ovarian failure. Jama 2003, 290:2127-2128. (Pubitemid 37432971)
16. Arnold AP, Chen X: What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol 2009, 30:1-9.
17. Komatsu T, Suzuki Y, Imai J, Sugano S, Hida M, Tanigami A, Muroi S, Yamada Y, Hanaoka K: Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzymerelated carboxypeptidase (mACE2). DNA Seq 2002, 13:217-220.
18. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, Philip N, Haystead TA, Donoghue M, Breitbart RE, Acton SL, Rockman HA, Coffman TM: Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. Journal of Clinical Investigation 2006, 116:2218-2225. (Pubitemid 44162331)
19. Ji H, Zheng W, Wu X, Liu J, Ecelbarger C, Watkins R, Arnold AP, Sandberg K: Sex chromosome effects unmasked in angiotensin-induced hypertension. Hypertension 2010.
20. Kang J, Price WE: Occurrence of phytoestrogens in municipal wastewater and surface waters. J Environ Monit 2009, 11:1477-1483.
21. Ji H, Menini S, Mok K, Zheng W, Pesce C, Kim J, Mulroney S, Sandberg K: Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol 2005, 288:F513-520. (Pubitemid 40279457)
22. Huentelman MJ, Zubcevic J, Katovich MJ, Raizada MK: Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. Regul Pept 2004, 122:61-67. (Pubitemid 39233638)
23. Shaltout HA, Figueroa JP, Rose JC, Diz DI, Chappell MC: Alterations in circulatory and renal angiotensin-converting enzyme and angiotensinconverting enzyme 2 in fetal programmed hypertension. Hypertension 2009, 53:404-408.
24. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P: Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002, 277:14838-14843. (Pubitemid 34952556)
25. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E: Brain-selective overexpression of human Angiotensin- converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106, 373-382.
26. Guy JL, Jackson RM, Jensen HA, Hooper NM, Turner AJ: Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J 2005, 272:3512-3520. (Pubitemid 41021165)
27. Lew RA, Warner FJ, Hanchapola I, Yarski MA, Manohar J, Burrell LM, Smith AI: Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp Physiol 2008, 93:685-693. (Pubitemid 351595050)
28. Copeland R: Enzymes: a practical introduction to structure, mechanism and data analysis New York: Wiley-VCH, Inc; 2000.
29. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D: ACE and ACE2 activity in diabetic mice. Diabetes 2006, 55:2132-2139. (Pubitemid 44509989)
30. Park S, Bivona BJ, Kobori H, Seth DM, Chappell MC, Lazartigues E, Harrison-Bernard LM: Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 2010, 298:F37-48.
31. Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith AI, Burrell LM, Angus PW: Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 2007, 47:387-395. (Pubitemid 47176156)
32. Leehey DJ, Singh AK, Bast JP, Sethupathi P, Singh R: Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Transl Res 2008, 151:208-216.
33. Xie X, Chen J, Wang X, Zhang F, Liu Y: Age-and gender-related difference of ACE2 expression in rat lung. Life Sci 2006, 78:2166-2171.
34. Brosnihan KB, Hodgin JB, Smithies O, Maeda N, Gallagher P: Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice. Exp Physiol 2008, 93:658-664. (Pubitemid 351595045)
35. Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, Ryan D, Fisher M, Williams D, Dales NA, Patane MA, Pantoliano MW: ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 2004, 279:17996-18007. (Pubitemid 38560569)
36. Lai ZW, Lew RA, Yarski MA, Mu FT, Andrews RK, Smith AI: The identification of a calmodulin-binding domain within the cytoplasmic tail of angiotensin-converting enzyme-2. Endocrinology 2009, 150:2376-2381.
37. Ji H, Menini S, Zheng W, Pesce C, Wu X, Sandberg K: Role of angiotensinconverting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats. Exp Physiol 2008, 93:648-657. (Pubitemid 351595057)
38. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000, 11:319-329. (Pubitemid 30064855)
39. Sandberg K: Mechanisms underlying sex differences in progressive renal disease. Gend Med 2008, 5:10-23. (Pubitemid 351506543)
40. Sandberg K, Ji H: Sex and the Renin Angiotensin System: Implications for Gender Differences in the Progression of Kidney Disease. Advances Renal Replacement Therapy 2003, 10:15-23. (Pubitemid 36278326)
41. Brosnihan KB, Neves LA, Joyner J, Averill DB, Chappell MC, Sarao R, Penninger J, Ferrario CM: Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension 2003, 42:749-753. (Pubitemid 37237320)
42. Shenoy V, Grobe JL, Qi Y, Ferreira AJ, Fraga-Silva RA, Collamat G, Bruce E, Katovich MJ: 17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 2009, 30:2309-2315.